ZA200201758B - Modified ubiquitin regulatory system. - Google Patents
Modified ubiquitin regulatory system. Download PDFInfo
- Publication number
- ZA200201758B ZA200201758B ZA200201758A ZA200201758A ZA200201758B ZA 200201758 B ZA200201758 B ZA 200201758B ZA 200201758 A ZA200201758 A ZA 200201758A ZA 200201758 A ZA200201758 A ZA 200201758A ZA 200201758 B ZA200201758 B ZA 200201758B
- Authority
- ZA
- South Africa
- Prior art keywords
- plant
- dna
- sequence
- new
- host cell
- Prior art date
Links
- 230000001105 regulatory effect Effects 0.000 title claims description 39
- 108090000848 Ubiquitin Proteins 0.000 title claims description 27
- 102000044159 Ubiquitin Human genes 0.000 title claims description 26
- 241000196324 Embryophyta Species 0.000 claims description 68
- 108090000623 proteins and genes Proteins 0.000 claims description 31
- 108020004414 DNA Proteins 0.000 claims description 28
- 238000000034 method Methods 0.000 claims description 26
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 23
- 241000209140 Triticum Species 0.000 claims description 13
- 239000013604 expression vector Substances 0.000 claims description 13
- 230000035939 shock Effects 0.000 claims description 13
- 235000021307 Triticum Nutrition 0.000 claims description 12
- 240000008042 Zea mays Species 0.000 claims description 10
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 10
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims description 9
- 235000009973 maize Nutrition 0.000 claims description 9
- 230000009261 transgenic effect Effects 0.000 claims description 6
- 230000001131 transforming effect Effects 0.000 claims description 5
- 240000005979 Hordeum vulgare Species 0.000 claims description 4
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 4
- 241000209510 Liliopsida Species 0.000 claims description 4
- 239000002773 nucleotide Substances 0.000 claims description 4
- 125000003729 nucleotide group Chemical group 0.000 claims description 4
- 239000013598 vector Substances 0.000 claims description 2
- 108700026220 vif Genes Proteins 0.000 claims 1
- 230000014509 gene expression Effects 0.000 description 43
- 210000004027 cell Anatomy 0.000 description 25
- 239000013612 plasmid Substances 0.000 description 22
- 210000002257 embryonic structure Anatomy 0.000 description 17
- 239000012634 fragment Substances 0.000 description 17
- 210000001519 tissue Anatomy 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 10
- 239000002245 particle Substances 0.000 description 10
- 230000009466 transformation Effects 0.000 description 10
- 239000000243 solution Substances 0.000 description 9
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 8
- 230000008929 regeneration Effects 0.000 description 8
- 238000011069 regeneration method Methods 0.000 description 8
- 239000000523 sample Substances 0.000 description 7
- 230000001939 inductive effect Effects 0.000 description 6
- 238000003556 assay Methods 0.000 description 5
- 239000007844 bleaching agent Substances 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 108700008625 Reporter Genes Proteins 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 239000000470 constituent Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000010353 genetic engineering Methods 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 230000001052 transient effect Effects 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 2
- 241000287937 Colinus Species 0.000 description 2
- 101150087882 GUS1 gene Proteins 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- 239000007993 MOPS buffer Substances 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 238000002635 electroconvulsive therapy Methods 0.000 description 2
- 241001233957 eudicotyledons Species 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000001307 helium Substances 0.000 description 2
- 229910052734 helium Inorganic materials 0.000 description 2
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 2
- 230000001744 histochemical effect Effects 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 229940063673 spermidine Drugs 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- JXCKZXHCJOVIAV-UHFFFAOYSA-N 6-[(5-bromo-4-chloro-1h-indol-3-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid;cyclohexanamine Chemical compound [NH3+]C1CCCCC1.O1C(C([O-])=O)C(O)C(O)C(O)C1OC1=CNC2=CC=C(Br)C(Cl)=C12 JXCKZXHCJOVIAV-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- -1 C 3 amino acid Chemical class 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 240000003133 Elaeis guineensis Species 0.000 description 1
- 235000001950 Elaeis guineensis Nutrition 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- 108010025815 Kanamycin Kinase Proteins 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- UOZODPSAJZTQNH-UHFFFAOYSA-N Paromomycin II Natural products NC1C(O)C(O)C(CN)OC1OC1C(O)C(OC2C(C(N)CC(N)C2O)OC2C(C(O)C(O)C(CO)O2)N)OC1CO UOZODPSAJZTQNH-UHFFFAOYSA-N 0.000 description 1
- 239000005595 Picloram Substances 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 108700009124 Transcription Initiation Site Proteins 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 239000002647 aminoglycoside antibiotic agent Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000002153 concerted effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 244000038559 crop plants Species 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000000408 embryogenic effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 101150054900 gus gene Proteins 0.000 description 1
- 230000008642 heat stress Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 229940014662 pantothenate Drugs 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229960001914 paromomycin Drugs 0.000 description 1
- UOZODPSAJZTQNH-LSWIJEOBSA-N paromomycin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)O[C@@H]1CO UOZODPSAJZTQNH-LSWIJEOBSA-N 0.000 description 1
- NQQVFXUMIDALNH-UHFFFAOYSA-N picloram Chemical compound NC1=C(Cl)C(Cl)=NC(C(O)=O)=C1Cl NQQVFXUMIDALNH-UHFFFAOYSA-N 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000031070 response to heat Effects 0.000 description 1
- 230000003938 response to stress Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 108020004418 ribosomal RNA Proteins 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 239000012146 running buffer Substances 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Luminescent Compositions (AREA)
- Gyroscopes (AREA)
- Control Of Eletrric Generators (AREA)
- Saccharide Compounds (AREA)
- Ticket-Dispensing Machines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99307158 | 1999-09-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200201758B true ZA200201758B (en) | 2003-08-27 |
Family
ID=8241614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200201758A ZA200201758B (en) | 1999-09-09 | 2002-03-01 | Modified ubiquitin regulatory system. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6878818B1 (pt) |
| EP (1) | EP1210446B1 (pt) |
| AT (1) | ATE328098T1 (pt) |
| AU (1) | AU769567B2 (pt) |
| CA (1) | CA2384517C (pt) |
| CZ (1) | CZ2002695A3 (pt) |
| DE (1) | DE60028388T2 (pt) |
| DK (1) | DK1210446T3 (pt) |
| ES (1) | ES2265978T3 (pt) |
| HU (1) | HU225171B1 (pt) |
| PL (1) | PL354747A1 (pt) |
| PT (1) | PT1210446E (pt) |
| WO (1) | WO2001018220A1 (pt) |
| ZA (1) | ZA200201758B (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001032897A2 (en) * | 1999-11-05 | 2001-05-10 | South African Sugar Association | A high level, stable, constitutive promoter element for plants |
| WO2001094394A2 (en) * | 2000-06-09 | 2001-12-13 | Prodigene, Inc. | Plant ubiquitin promoter sequences and methods of use |
| DE10224889A1 (de) | 2002-06-04 | 2003-12-18 | Metanomics Gmbh & Co Kgaa | Verfahren zur stabilen Expression von Nukleinsäuren in transgenen Pflanzen |
| CA3004022C (en) * | 2011-03-25 | 2020-07-28 | Monsanto Technology Llc | Plant regulatory elements and uses thereof |
| BR122020011572B1 (pt) | 2013-03-14 | 2021-10-13 | Monsanto Technology Llc | Cassete de expressão compreendendo elemento regulador de planta e método para produzir uma planta transgênica |
| CN105518136A (zh) | 2013-07-10 | 2016-04-20 | 巴斯夫欧洲公司 | 用于通过抑制CYP51基因表达来控制致植物病真菌和卵菌的RNAi |
| TW201527313A (zh) * | 2013-12-31 | 2015-07-16 | Dow Agrosciences Llc | 新穎玉米泛素啓動子（二） |
| EP3354738A1 (en) | 2017-01-30 | 2018-08-01 | Kws Saat Se | Transgenic maize plant exhibiting increased yield and drought tolerance |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE68918494T2 (de) | 1988-05-17 | 1995-03-23 | Lubrizol Genetics Inc | Pflanzliches Ubiquitinpromotorsystem. |
| WO2000015810A1 (en) * | 1998-09-10 | 2000-03-23 | Monsanto Plc | Isoforms of starch branching enzyme ii (sbe-iia and sbe-iib) from wheat |
-
2000
- 2000-09-07 PL PL00354747A patent/PL354747A1/xx not_active IP Right Cessation
- 2000-09-07 CZ CZ2002695A patent/CZ2002695A3/cs unknown
- 2000-09-07 AU AU75155/00A patent/AU769567B2/en not_active Expired
- 2000-09-07 ES ES00964125T patent/ES2265978T3/es not_active Expired - Lifetime
- 2000-09-07 HU HU0202852A patent/HU225171B1/hu unknown
- 2000-09-07 DE DE60028388T patent/DE60028388T2/de not_active Expired - Lifetime
- 2000-09-07 PT PT00964125T patent/PT1210446E/pt unknown
- 2000-09-07 AT AT00964125T patent/ATE328098T1/de active
- 2000-09-07 US US10/069,909 patent/US6878818B1/en not_active Expired - Lifetime
- 2000-09-07 WO PCT/EP2000/008690 patent/WO2001018220A1/en active IP Right Grant
- 2000-09-07 CA CA2384517A patent/CA2384517C/en not_active Expired - Lifetime
- 2000-09-07 DK DK00964125T patent/DK1210446T3/da active
- 2000-09-07 EP EP00964125A patent/EP1210446B1/en not_active Expired - Lifetime
-
2002
- 2002-03-01 ZA ZA200201758A patent/ZA200201758B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0202852A3 (en) | 2004-09-28 |
| EP1210446B1 (en) | 2006-05-31 |
| CA2384517C (en) | 2010-07-20 |
| AU769567B2 (en) | 2004-01-29 |
| DK1210446T3 (da) | 2006-09-25 |
| PL354747A1 (en) | 2004-02-23 |
| PT1210446E (pt) | 2006-10-31 |
| ES2265978T3 (es) | 2007-03-01 |
| AU7515500A (en) | 2001-04-10 |
| DE60028388T2 (de) | 2007-04-26 |
| EP1210446A1 (en) | 2002-06-05 |
| HU225171B1 (en) | 2006-07-28 |
| WO2001018220A1 (en) | 2001-03-15 |
| DE60028388D1 (de) | 2006-07-06 |
| HUP0202852A2 (hu) | 2002-12-28 |
| CZ2002695A3 (cs) | 2002-07-17 |
| CA2384517A1 (en) | 2001-03-15 |
| ATE328098T1 (de) | 2006-06-15 |
| US6878818B1 (en) | 2005-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9756871B2 (en) | TAL-mediated transfer DNA insertion | |
| AU738153C (en) | Methods for the production of stably-transformed, fertile wheat employing agrobacterium-mediated transformation and compositions derived therefrom | |
| Coutu et al. | pORE: a modular binary vector series suited for both monocot and dicot plant transformation | |
| EP0781849B1 (en) | Method employing tissue specific promoter | |
| US20140363561A1 (en) | Tal-mediated transfer dna insertion | |
| WO1997037012A9 (en) | Single-step excision means | |
| WO1999005902A1 (en) | Transgenic plants tolerant of salinity stress | |
| JP2000516806A (ja) | シュート分裂組織特異的プロモーター配列 | |
| Chakraborti et al. | Cre/lox system to develop selectable marker free transgenic tobacco plants conferring resistance against sap sucking homopteran insect | |
| Kopertekh et al. | Developmentally regulated site-specific marker gene excision in transgenic B. napus plants | |
| US6878818B1 (en) | Modified ubiquitin regulatory system | |
| JP2022075843A (ja) | 植物調節エレメント及びその使用 | |
| CN107058317B (zh) | 一种花粉特异性启动子及其应用 | |
| TWI534265B (zh) | 用於操縱植物之光合細胞中果聚糖生合成之方法、基因建構體及基因轉殖植物細胞 | |
| Zuo et al. | Applications of chemical-inducible expression systems in functional genomics and biotechnology | |
| WO2007028979A1 (en) | Plant transformation | |
| JPH08506003A (ja) | クルーシファａｃｃシンターゼおよびその利用 | |
| JPH1175594A (ja) | チオニン遺伝子を用いた複数病害抵抗性植物の作出方法 | |
| CN116606856B (zh) | 一种水稻绿色组织特异性启动子pOsPTHR及其应用 | |
| CN116606855B (zh) | 一种水稻绿色组织特异性启动子pOsRBBI3及其应用 | |
| Sharwood et al. | Chapter 19 Engineering the Sunflower Rubisco Subunits into Tobacco Chloroplasts: New Considerations | |
| JP2005143338A (ja) | カルス及び種子胚特異的発現活性を有するプロモーター | |
| CN116218899A (zh) | 水稻特异调控粒宽基因slg2及其应用 | |
| CN116875599A (zh) | 一种水稻绿色组织特异性启动子pOsCCA1及其应用 | |
| JP3885134B2 (ja) | 転写活性化因子 |